New diabetes pill rybelsus under Real-World safety check in korea
NCT ID NCT05714683
First seen Jan 08, 2026 · Last updated May 23, 2026 · Updated 19 times
Summary
This study looks at the safety and effectiveness of Rybelsus, a daily pill for type 2 diabetes, when used in everyday medical practice in Korea. About 600 adults will take the medicine as their doctor prescribes, and researchers will track any side effects and blood sugar changes over 26 weeks. The goal is to see how well the drug works outside of strict research settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.